Density Functional Theory, Molecular-Docking Studies and Inhibition Effects of Pharmaceutical Active Ingredients on Xanthine Oxidase

被引:0
|
作者
Kaya, Mustafa Oguzhan [1 ]
Dandan, Enes [1 ]
Demirci, Tuna [2 ]
Ozdemir, Oguzhan [3 ]
Kaya, Yesim [1 ]
Arslan, Mustafa [4 ]
机构
[1] Kocaeli Univ, Fac Arts & Sci, Dept Chem, Kocaeli, Turkiye
[2] Duzce Univ, Sci & Technol Res Lab, Duzce, Turkiye
[3] Batman Univ, Tech Sci Vocat Sch, Vet Sci Dept, Raman Campus, Batman, Turkiye
[4] Sakarya Univ, Fac Sci, Dept Chem, Sakarya, Turkiye
关键词
active pharmaceutical ingredient; xanthine oxidase (XO); density functional theory (DFT); molecular docking; BOVINE-MILK; DEHYDROGENASE; PURIFICATION; CONVERSION; DISCOVERY; CLEAVAGE; EFFICACY; DESIGN; UREASE; SAFETY;
D O I
10.1007/s11094-025-03320-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Xanthine oxidase (XO) is a crucial part of human metabolism because of its activity on purine metabolism. In this study, drospirenone, dutasteride, ketoprofen, miconazole, mirabegron, mycophenolate mofetil, nimesulide, phenylephrine hydrochloride, prasugrel hydrochloride, ranolazine, tropicamide, and melatonin were used as drug active ingredients and the inhibitory effect of 12 drug active ingredients on XO was evaluated in vitro at the concentration of each compound required to inhibit it by 50% (IC50). As a result of the study, dutasteride exhibited the lowest highest occupied molecular orbital-lowest unoccupied molecular orbital (triangle E = 2.522 eV) energy gap, the best isotropic polarizability (331.020 atomic units), the best docking score (-11.30 kcal/mol), and the best inhibition value (IC50 = 65.80 mu M).
引用
收藏
页码:1650 / 1658
页数:9
相关论文
共 50 条
  • [1] Density functional theory (DFT), molecular docking, and xanthine oxidase inhibitory studies of dinaphthodiospyrol S from Diospyros kaki L
    Abu-Izneid, Tareq
    Rauf, Abdur
    Ahmad, Zubair
    Wadood, Abdul
    Ayub, Khurshid
    Muhammad, Naveed
    Al-Awthan, Yahya S.
    Maqbool, Maria
    Bahattab, Omar S.
    Hemeg, Hassan A.
    Naz, Saima
    Formanowicz, Dorota
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (02)
  • [2] Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones
    Zafar, Humaira
    Iqbal, Sarosh
    Javaid, Sumaira
    Khan, Khalid M.
    Choudhary, Muhammad I.
    MEDICINAL CHEMISTRY, 2018, 14 (05) : 524 - 535
  • [3] Molecular Docking Studies on Isocytosine Analogues as Xanthine Oxidase Inhibitors
    Roy, Subhajit
    Narang, Bawneet K.
    Gupta, Manish K.
    Abbot, Vikrant
    Singh, Virender
    Rawal, Ravindra K.
    DRUG RESEARCH, 2018, 68 (07) : 395 - 402
  • [4] A density functional study of active site models for xanthine oxidase
    Bray, MR
    Deeth, RJ
    INORGANIC CHEMISTRY, 1996, 35 (19) : 5720 - 5724
  • [5] Investigating the inhibition of xanthine oxidase by five catechins: Kinetic studies, spectroscopy, molecular docking, and dynamics simulations
    Liu, Xiaoze
    Zhang, Wen
    Chen, Jingwen
    Fu, Ruihui
    Lin, Xue
    Zhou, Shaobo
    Wang, Lu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 281
  • [6] Inhibition and molecular mechanism of diosmetin against xanthine oxidase by multiple spectroscopies and molecular docking
    Liu, Yongjie
    Chen, Hao
    Xiang, Huilong
    Lei, Huan
    Zhang, Di
    Qin, Yinsheng
    Xu, Lingyun
    NEW JOURNAL OF CHEMISTRY, 2020, 44 (17) : 6799 - 6809
  • [7] Eutectic Mixtures to Enhance the Solubility of Active Pharmaceutical Ingredients: Density Functional Theory and Infrared Spectroscopy Approaches
    Raman, Anirudh Pratap Singh
    Jain, Pallavi
    Kumar, Ajay
    Singh, Prashant
    Kumari, Kamlesh
    Bahadur, Indra
    Mohammad, Faruq
    Kaushik, Nagendra Kumar
    CHEMISTRYSELECT, 2023, 8 (25):
  • [8] Synthesis, Biological Evaluation, and Molecular Docking Studies of Hydrazones as Novel Xanthine Oxidase Inhibitors
    Xue, Ling-Wei
    Li, Shi-Tong
    Han, Yong-Jun
    Luo, Xiao-Qiang
    ACTA CHIMICA SLOVENICA, 2022, 69 (02) : 385 - 392
  • [9] Experimental and density functional theory studies on benzalkonium ibuprofenate, a double active pharmaceutical ingredient
    Hussan, K. P. Safna
    Thayyil, M. Shahin
    Rajan, Vijisha K.
    Muraleedharan, K.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 72 : 113 - 121
  • [10] Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies
    Gulati, Harmandeep Kaur
    Khanna, Aanchal
    Kumar, Nitish
    Sharma, Anchal
    Singh, Jatindervir
    Bhagat, Kavita
    Bedi, Preet Mohinder Singh
    ARCHIV DER PHARMAZIE, 2024, 357 (04)